Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SPON ADS NEW
-
Total 13F shares
-
2,888,283
-
Share change
-
-42,440
-
Total reported value
-
$866,485
-
Put/Call ratio
-
0%
-
Price per share
-
$0.30
-
Number of holders
-
17
-
Value change
-
-$51,642
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of ASLAN PHARMACEUTICALS LTD - SPON ADS NEW (ASLN) as of Q2 2024
As of 30 Jun 2024,
ASLAN PHARMACEUTICALS LTD - SPON ADS NEW (ASLN) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,888,283 shares.
The largest 10 holders included
BVF INC/IL, Velan Capital Investment Management LP, Shay Capital LLC, Sio Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Schonfeld Strategic Advisors LLC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, TWO SIGMA SECURITIES, LLC, and Onyx Bridge Wealth Group LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.